Gladstone NOW: The Campaign Join Us on the Journey✕
Bruce Conklin, MD, introduces you to CRISPR, a disruptive technology influencing advances in treatment and cures of diseases through gene editing. Conklin walks you through how CRISPR works before diving into its evolution in his lab at Gladstone, using application examples such as treating cancer, curing Alzheimer’s, and testing drug therapies to prevent cardiac damage in COVID-19 patients. You’ll also hear about this DNA-editing technology’s bright future expanding its reach into cures for more diseases.
Support Our COVID-19 Research Efforts
Gladstone scientists are moving quickly to respond to the coronavirus outbreak. Help us end this pandemic.
Ask a Scientist: When Will Immunotherapy Work on Common Cancers?
Article
June 11, 2025
Ask a Scientist: When Will Immunotherapy Work on Common Cancers?
For Cancer Immunotherapy Month, Karin Pelka answers questions about how immunotherapy can treat patients with solid tumors and the challenges that scientists are working to overcome.
Gladstone Experts Cancer Genomic Immunology Data Science and Biotechnology Pelka LabCulture Is Our Superpower | The Gladstone Difference
Video
May 27, 2025
Culture Is Our Superpower | The Gladstone Difference
Discover how Gladstone fosters an environment in which people are having fun, working hard, and driven to save human lives.
Gladstone Experts Graduate Students and Postdocs Institutional NewsScience in Seconds | Gladstone Researchers Tackle Charcot-Marie-Tooth (CMT) Disease
Video
May 14, 2025
Science in Seconds | Gladstone Researchers Tackle Charcot-Marie-Tooth (CMT) Disease
Bruce Conklin and his team at Gladstone are tackling Charcot-Marie-Tooth (CMT) disease, the most common inherited neurological disorders—for which there is currently no cure.
Gladstone Experts Conklin Lab CRISPR/Gene Editing